2015
Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis
Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS. Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis. Blood 2015, 126: 346-353. PMID: 26048910, DOI: 10.1182/blood-2015-02-627414.Peer-Reviewed Original ResearchConceptsLong-term neurocognitive functioningAcute lymphoblastic leukemiaCranial radiationNeurocognitive functioningIntelligence quotientChildhood acute lymphoblastic leukemiaContinuous first remissionSurvivors of childhoodDatabase of AbstractsConfidence intervalsHealthy control groupStandard deviation scoreFine motor domainNeurocognitive domainsReviews of EffectsMEDLINE/PubMedFirst remissionFull-scale intelligence quotientPerformance intelligence quotientLymphoblastic leukemiaInformation processing speedDeviation scoreSD scoreModerate impairmentMultiple neurocognitive domains
1992
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.
Bracken M, Shepard M, Collins W, Holford T, Baskin D, Eisenberg H, Flamm E, Leo-Summers L, Maroon J, Marshall L, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. Journal Of Neurosurgery 1992, 76: 23-31. PMID: 1727165, DOI: 10.3171/jns.1992.76.1.0023.Peer-Reviewed Original ResearchConceptsHours of injuryAcute spinal cord injurySpinal cord injuryNaloxone treatmentCord injuryMotor functionSecond National Acute Spinal Cord Injury StudyNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudySpinal Cord Injury StudyAcute spinal cord traumaPreservation of motorTrial of methylprednisoloneSpinal cord traumaTotal sensoryPlacebo groupCord traumaNeurological functionStudy doseEmergency roomMethylprednisoloneInjury studiesMortality ratePatientsSensory function